TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women

scientific article published on 07 June 2014

TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S13277-014-2170-Z
P698PubMed publication ID24903383

P2093author name stringWu-Hsien Kuo
Shun-Fa Yang
Ming-Ju Hsieh
Hsiang-Lin Lee
Hsiu-Ting Tsai
Hui-Ling Chiou
Yi-Sheng Liou
Chen-Chieh Yang
Min-Chieh Hsin
P2860cites workTreatment of hepatocellular carcinomaQ73043043
Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26Q28273704
CpG island methylation and expression of tumour-associated genes in lung carcinomaQ30320221
Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.Q33514753
Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinomaQ33544926
TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.Q33754007
Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysmsQ34074796
Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.Q34341560
Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progressionQ34573212
Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinomaQ35699313
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.Q35927161
Management of hepatocellular carcinoma in JapanQ36433760
Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in miceQ37204756
Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survivalQ37351433
Challenge and hope in radiotherapy of hepatocellular carcinomaQ37400936
Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinomaQ38585070
Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysisQ39149008
Curcumin effect on MMPs and TIMPs genes in a breast cancer cell line.Q39275147
MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cellsQ39913331
Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3.Q40644810
Alcohol modulation of cardiac matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs favors collagen accumulationQ41774444
Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.Q42925381
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissuesQ43200969
Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cellsQ43481636
Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expressionQ44017139
Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese populationQ44037768
Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean populationQ44581830
Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in miceQ46232844
Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.Q48048643
Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.Q50863404
CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.Q54321502
Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer.Q54462431
Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors.Q54785034
Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.Q55471677
Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patientsQ57607660
Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related riskQ58814554
P433issue9
P304page(s)8999-9007
P577publication date2014-06-07
P1433published inTumor BiologyQ15757842
P1476titleTIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women
P478volume35

Reverse relations

cites work (P2860)
Q61444155Association of TIMP4 gene variants with steroid-induced osteonecrosis of the femoral head in the population of northern China
Q42146970Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study
Q36299328Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer
Q64057740Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study
Q92277219TIMP-3 as a therapeutic target for cancer

Search more.